Drug trials in children: problems and the way forward
Open Access
- 1 February 2000
- journal article
- review article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 49 (2) , 93-97
- https://doi.org/10.1046/j.1365-2125.2000.00125.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric useBritish Journal of Clinical Pharmacology, 1999
- Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indicationsBritish Journal of Clinical Pharmacology, 1999
- Licensing of medicinesArchives of Disease in Childhood, 1998
- Induction of CYP1A2 activity by carbamazepine in children using the caffeine breath testBritish Journal of Clinical Pharmacology, 1998
- Drug toxicity and surveillance in childrenBritish Journal of Clinical Pharmacology, 1996
- Drug toxicity and surveillance in childrenBritish Journal of Clinical Pharmacology, 1996
- Morphine, morphine‐6‐glucuronide and morphine‐3‐glucuronide pharmacokinetics in newborn infants receiving diamorphine infusionsBritish Journal of Clinical Pharmacology, 1996
- LORAZEPAM VERSUS DIAZEPAM IN THE ACUTE TREATMENT OF EPILEPTIC SEIZURES AND STATUS EPILEPTICUSDevelopmental Medicine and Child Neurology, 1995
- Valproate Metabolites in Serum and Urine During Antiepileptic Therapy in Children with Infantile Spasms: Abnormal Metabolite Pattern Associated with Reversible HepatotoxicityEpilepsia, 1992
- The Human Hepatic Cytochromes P450 Involved in Drug MetabolismCritical Reviews in Toxicology, 1992